Call for a consensual definition of dyslipidemia in coronary angiography trials
Dyslipidemia is extensively analyzed in clinical trials investigating its role as a risk factor for coronary artery disease (CAD). However, its definition varies vastly among studies, leading to different attributions to the variable dyslipidemia. The objectives of this study are to verify the hypot...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1506149/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832539891636895744 |
|---|---|
| author | Aurélien Clerc Mario Togni Stephane Cook |
| author_facet | Aurélien Clerc Mario Togni Stephane Cook |
| author_sort | Aurélien Clerc |
| collection | DOAJ |
| description | Dyslipidemia is extensively analyzed in clinical trials investigating its role as a risk factor for coronary artery disease (CAD). However, its definition varies vastly among studies, leading to different attributions to the variable dyslipidemia. The objectives of this study are to verify the hypothesis of a lack of a consensual definition of dyslipidemia in coronary angiography studies and to propose a consensual definition of dyslipidemia, considering the influence of each serum lipid parameter on mortality. A systematic search of coronary angiography studies focusing on dyslipidemia was conducted. We listed definitions and their references in the 258 articles the research found. Out of the 258 articles retrieved in the search, 52 studies (20%) provided a definition of dyslipidemia, and 20 (8%) mentioned the source. We identified 39 different definitions. To mitigate misinterpretations of cardiovascular risk factors, we propose the use of the “lipid triad” components to define dyslipidemia: LDL-cholesterol >3.0 mmol/L for primary prevention and >2.6 mmol/L or >1.4 mmol/L for secondary prevention in patients over/under 75 years old, respectively; or HDL-cholesterol <1.3 mmol/L (women) and <1.0 mmol/L (men); or triglycerides >1.7 mmol/L. |
| format | Article |
| id | doaj-art-50704979074d4530a8962045b5ac6e4e |
| institution | Kabale University |
| issn | 2297-055X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj-art-50704979074d4530a8962045b5ac6e4e2025-02-05T07:32:58ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-02-011210.3389/fcvm.2025.15061491506149Call for a consensual definition of dyslipidemia in coronary angiography trialsAurélien ClercMario TogniStephane CookDyslipidemia is extensively analyzed in clinical trials investigating its role as a risk factor for coronary artery disease (CAD). However, its definition varies vastly among studies, leading to different attributions to the variable dyslipidemia. The objectives of this study are to verify the hypothesis of a lack of a consensual definition of dyslipidemia in coronary angiography studies and to propose a consensual definition of dyslipidemia, considering the influence of each serum lipid parameter on mortality. A systematic search of coronary angiography studies focusing on dyslipidemia was conducted. We listed definitions and their references in the 258 articles the research found. Out of the 258 articles retrieved in the search, 52 studies (20%) provided a definition of dyslipidemia, and 20 (8%) mentioned the source. We identified 39 different definitions. To mitigate misinterpretations of cardiovascular risk factors, we propose the use of the “lipid triad” components to define dyslipidemia: LDL-cholesterol >3.0 mmol/L for primary prevention and >2.6 mmol/L or >1.4 mmol/L for secondary prevention in patients over/under 75 years old, respectively; or HDL-cholesterol <1.3 mmol/L (women) and <1.0 mmol/L (men); or triglycerides >1.7 mmol/L.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1506149/fulldyslipidemia (DLP)coronary angiography (CA)cardiovascular risk factorcoronary artery diseasedefinition |
| spellingShingle | Aurélien Clerc Mario Togni Stephane Cook Call for a consensual definition of dyslipidemia in coronary angiography trials Frontiers in Cardiovascular Medicine dyslipidemia (DLP) coronary angiography (CA) cardiovascular risk factor coronary artery disease definition |
| title | Call for a consensual definition of dyslipidemia in coronary angiography trials |
| title_full | Call for a consensual definition of dyslipidemia in coronary angiography trials |
| title_fullStr | Call for a consensual definition of dyslipidemia in coronary angiography trials |
| title_full_unstemmed | Call for a consensual definition of dyslipidemia in coronary angiography trials |
| title_short | Call for a consensual definition of dyslipidemia in coronary angiography trials |
| title_sort | call for a consensual definition of dyslipidemia in coronary angiography trials |
| topic | dyslipidemia (DLP) coronary angiography (CA) cardiovascular risk factor coronary artery disease definition |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1506149/full |
| work_keys_str_mv | AT aurelienclerc callforaconsensualdefinitionofdyslipidemiaincoronaryangiographytrials AT mariotogni callforaconsensualdefinitionofdyslipidemiaincoronaryangiographytrials AT stephanecook callforaconsensualdefinitionofdyslipidemiaincoronaryangiographytrials |